Halogenation of drugs enhances membrane binding and permeation.

Chembiochem

Biophysical Chemistry, Biozentrum, University of Basel, Klingelbergstrasse 70, 4056 Basel, Switzerland.

Published: May 2004

Halogenation of drugs is commonly used to enhance membrane binding and permeation. We quantify the effect of replacing a hydrogen residue by a chlorine or a trifluoromethyl residue in position C-2 of promazine, perazine, and perphenazine analogues. Moreover, we investigate the influence of the position (C-6 and C-7) of residue CF(3) in benzopyranols. The twelve drugs are characterized by surface activity measurements, which yield the cross-sectional area, the air-water partition coefficient, and the critical micelle concentration. By using the first two parameters (A(D) and K(aw)) and the appropriate membrane packing density, the lipid-water partition coefficients, are calculated in excellent agreement with the lipid-water partition coefficients measured by means of isothermal titration calorimetry for small unilamellar vesicles of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine. Replacement of a hydrogen residue by a chlorine and a trifluoromethyl residue enhances the free energy of partitioning into the lipid membrane, on average by deltaG(lw) approximately -1.3 or -4.5 kJ mol(-1), respectively, and the permeability coefficient by a factor of approximately 2 or approximately 9, respectively. Despite exhibiting practically identical hydrophobicities, the two benzopyranol analogues differ in their permeability coefficients by almost an order of magnitude; this is due to their different cross-sectional areas at the air-water and lipid-water interfaces.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cbic.200400017DOI Listing

Publication Analysis

Top Keywords

halogenation drugs
8
membrane binding
8
binding permeation
8
hydrogen residue
8
residue chlorine
8
chlorine trifluoromethyl
8
trifluoromethyl residue
8
lipid-water partition
8
partition coefficients
8
residue
5

Similar Publications

Up to 80% of children/adolescents with Graves' disease (GD) may require second-line treatment with either surgery or radioactive iodine (RAI) therapy after treatment with antithyroid drugs. These interventions aim to induce permanent hypothyroidism, but are not always successful. We aimed to evaluate the initial success rate (within the first year) of RAI treatment and its determining factors as second-line treatment in teenagers with GD.

View Article and Find Full Text PDF

Visible-Light-Induced Radical Carbon Oximation of Styrenes Using -Nitrosoamine and Organic Halides.

J Org Chem

December 2024

Jiangxi Province Key Laboratory of Natural and Biomimetic Drugs Research, College of Chemistry and Materials, Jiangxi Normal University, Nanchang, Jiangxi 330022, P. R. China.

An efficient visible-light-induced radical carbon oximation of styrenes with 1-nitrosopyrrolidine and organic halides is developed. The reaction proceeds smoothly in the absence of a transition metal and a photocatalyst under mild conditions, producing a wide range of functionalized oximes in moderate to good yields. Mechanistic studies reveal that the reaction involves the generation of nucleophilic α-amino alkyl radicals and subsequent halogen atom transfer (XAT) with organic halides.

View Article and Find Full Text PDF

Modeling Clinical Radioiodine Uptake By Using Organoids Derived From Differentiated Thyroid Cancer.

Endocrinology

November 2024

Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu 610000, China.

Article Synopsis
  • The study focuses on radioiodine-refractory differentiated thyroid cancer (RAI-R DTC), which is a major cause of thyroid-related deaths and has limited models for predicting iodine uptake.
  • Researchers created a primary tumor-derived organoid model from 20 DTC patients to assess and predict radioiodine uptake, comparing the organoids' properties to the original tumor tissue.
  • The results showed that RAI-avid organoids had significantly higher iodine uptake than RAI-R organoids, with a predictive accuracy of 95% for determining iodine-refractory cases, and highlighted the potential of using tyrosine kinase inhibitors to resensitize iodine uptake in certain patients.
View Article and Find Full Text PDF

Squaric acid derivatives with cytotoxic activity-a review.

Chem Biol Interact

December 2024

Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Build. 9, 1113, Sofia, Bulgaria; Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, Dunav -2 Street, 1000, Sofia, Bulgaria.

3,4-Dihydroxycyclobut-3-ene-1,2-dione (squaric acid, SQ) is the most important representative of the oxocarbon acids family. Squaric acid derivatives can be promising pharmaceutical agents, due to their unique structural properties, from which novel drugs benefit: a planar aromatic ring, the ability to form hydrogen bonds, good reactivity and similarity with carboxylate, phosphate and amide groups. These properties make it suitable for three major applications in cancer treatment.

View Article and Find Full Text PDF

Diarylmethanes play, in part, a pivotal role in the design of highly potent, chiral, nonracemic drugs whose bioactivity is typically affected by the substitution pattern of their arene units. In this context, certain arenes such as -substituted benzenes or unsubstituted heteroarenes cause particular synthetic challenges, since such isosteric residues at the central methane carbon atom are typically indistinguishable for a chiral catalyst. Hence, the stereoselective incorporation of isosteric (hetero)arenes into chiral methane scaffolds requires the use of stoichiometrically differentiated building blocks, which is typically realized through preceding redox-modifying operations such as metalation or halogenation and thus associated with disadvantageous step- and redox-economic traits.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!